Healthcare, Pharma & Life Sciences

Global Dental Community Secures Balanced Transition in Mercury Phase-Out at COP6

Image
Global Dental Community Secures Balanced Transition in Mercury Phase-Out at COP6

SHERIDAN, WYOMING - November 10, 2025 - A pivotal decision at the Sixth Conference of the Parties (COP6) to the Minamata Convention on Mercury has extended the global phase-out date for dental amalgam from 2030 to 2034. The outcome represents a major win for oral and public health, driven by coordinated advocacy from the FDI World Dental Federation (FDI) and the International Association for Dental, Oral, and Craniofacial Research (IADR).

A Milestone for Equity and Patient-Centered Care

The new COP6 agreement establishes that the manufacture, import, and export of dental amalgam will cease globally by 2034. Crucially, it includes an exemption permitting its use "when its use is considered necessary by the dental practitioner based on the needs of the patient." This ensures clinicians can continue providing essential restorative care in cases where alternatives remain inaccessible or unsuitable-especially in low-resource settings.

FDI Highlights 2025 World Dental Development Fund Recipients Advancing Community Oral Health Across Africa

Image
FDI Highlights 2025 World Dental Development Fund Recipients Advancing Community Oral Health Across Africa

SHERIDAN, WYOMING - November 10, 2025 - The FDI World Dental Federation has named three innovative projects from Nigeria, Kenya, and Tanzania as recipients of the 2025 World Dental Development Fund (WDDF), underscoring a strong commitment to equitable access to oral health care in low-resource settings. Each project demonstrates how community-based initiatives can integrate dental care into broader health and social development programs.

Integrating Oral Health Into Nutrition Programs in Nigeria

In Oyo State, Nigeria, the NOMALnutrition initiative is redefining community health delivery by embedding oral health care within existing nutrition programmes. Partnering with six organizations that already support vulnerable populations such as children living on the street and elderly rural residents, the project will reach approximately 500 people each month.

Five Years of Global Impact: FDI's Tobacco Cessation Project Transforms Dental Practice Worldwide

Image
Five Years of Global Impact: FDI’s Tobacco Cessation Project Transforms Dental Practice Worldwide

SHERIDAN, WYOMING - November 10, 2025 - Over the past five years, FDI World Dental Federation's Tobacco Cessation project has redefined the role of oral health professionals in combating one of the world's leading causes of preventable disease and death. By integrating evidence-based cessation strategies into dental practice, the initiative has empowered dentists and hygienists worldwide to help patients take meaningful steps toward quitting tobacco.

Building Global Capacity Through Education

Launched in 2020, the project established an ambitious goal: to embed tobacco cessation counseling directly into everyday dental care. FDI's interactive workshops-centered on the 5As (Ask, Advise, Assess, Assist, Arrange) and 5Rs (Relevance, Risks, Rewards, Roadblocks, Repetition)-equip participants with the communication tools and clinical confidence needed to address tobacco use during routine appointments.

Globus Medical Names Keith Pfeil CEO as Leadership Transition Aligns with Strong Q2 Sales Performance

Image

SHERIDAN, WYOMING – July 21, 2025 – Globus Medical, Inc. has announced a significant leadership transition, positioning its executive team for continued strategic growth in the musculoskeletal technology sector. Effective July 21, 2025, Keith Pfeil assumed the role of President and Chief Executive Officer, succeeding Daniel Scavilla, who stepped down to pursue another opportunity. Additionally, Kyle Kline was appointed Senior Vice President and Chief Financial Officer.

Leadership Shifts Focused on Strategic Growth

Globus Medical to Release Q2 2025 Financial Results and Host Investor Call on August 7

Image

SHERIDAN, WYOMING – July 21, 2025 – Globus Medical, Inc. has scheduled the announcement of its financial results for the second quarter ended July 21, 2025, for Thursday, July 21, 2025, after market close. The musculoskeletal technology leader will publish the earnings release on its investor relations website at www.investors.globusmedical.com.

Investor Call Scheduled for August 7

Following the earnings release, Globus Medical will host a teleconference with the investment community at 4:30 p.m. Eastern Time on the same day. The company offers multiple ways for stakeholders to join the event:

Globus Medical Expands Surgical Power Portfolio with DuraPro™ and Advanced Navigation Solutions

Image

SHERIDAN, WYOMING – July 21, 2025 – Globus Medical, Inc. has announced the expansion of its Excelsius™ navigation capabilities with the introduction of DuraPro™, a next-generation oscillating system designed to enhance surgical precision while safeguarding delicate tissue. As part of the company’s Power Portfolio, DuraPro™ aims to optimize procedural workflows by combining advanced oscillating technology with integrated navigation.

Advancing the High-Speed Drill Market with Next-Generation Oscillation

Globus Medical Authorizes $500 Million Share Repurchase to Strengthen Shareholder Value

Image

SHERIDAN, WYOMING – July 21, 2025 – Globus Medical, Inc. (NYSE: GMED), a global leader in musculoskeletal solutions, today announced a significant strategic initiative with the authorization of a share repurchase program of up to $500 million of the company’s outstanding common stock. The move underscores Globus Medical’s confidence in its long-term business fundamentals and commitment to delivering sustained value for shareholders.

Strategic Response to Market Valuation Trends

Empowering Early Caries Management with KaVo DIAGNOcam Vision Full HD

Image
Empowering Early Caries Management with KaVo DIAGNOcam Vision Full HD

SHERIDAN, WYOMING - July 21, 2025 - Dental professionals seeking to preserve patients' natural dentition now have a new tool for proactive care: the KaVo DIAGNOcam Vision Full HD system, designed to enhance early caries detection and treatment planning without the risks associated with radiation. By addressing common diagnostic challenges, this technology aims to set new standards in early caries management and patient communication.

Meeting the Limitations of Traditional Diagnostic Methods

Conventional methods such as bitewing radiography and visual-tactile examinations often fall short in detecting interproximal or secondary caries at early stages. Frequently, lesions either progress unnoticed between check-ups or remain inactive for extended periods, leaving practitioners uncertain about the right course of action. The KaVo DIAGNOcam Vision Full HD responds directly to these gaps.

KaVo Launches DIAGNOcam Vision Full HD for Simultaneous Triple Dental Diagnostics

Image

SHERIDAN, WYOMING – July 21, 2025 – KaVo Dental has launched the DIAGNOcam Vision Full HD, an innovative dental diagnostic device that enables simultaneous capture, presentation, and storage of three diagnostic images in less than one second. Designed to integrate seamlessly into existing clinical workflows, this advanced system supports dental professionals in enhancing diagnostic accuracy while improving patient communication and care.

Revolutionizing Dental Diagnostics with Real-Time Triple Imaging

With the introduction of the DIAGNOcam Vision Full HD, KaVo Dental brings a significant technological advancement to the dental sector. The device combines cutting-edge transillumination and fluorescence technology, allowing for high-definition, radiation-free imaging that supports early caries detection and more effective patient consultations.

Key features of the DIAGNOcam Vision Full HD include:

KaVo Launches MASTERmatic LUX M45 L to Advance Precision and Safety in Dental Practices

Image
KaVo Launches MASTERmatic LUX M45 L to Advance Precision and Safety in Dental Practices

SHERIDAN, WYOMING - July 21, 2025 - KaVo, a renowned innovator in dental technology, has officially launched the MASTERmatic LUX M45 L High-Speed Handpiece, expanding its MASTER series with a model engineered for advanced precision, improved visibility, and enhanced patient care. The introduction of this high-performance device marks a strategic move to strengthen KaVo's footprint in the competitive market for dental treatment solutions.

Advancing Ergonomics and Patient Safety in Dentistry

With the MASTERmatic LUX M45 L, KaVo is addressing key demands of modern dental practices by combining ergonomic design with cutting-edge technology. According to the company's announcement, the new handpiece is specifically developed to improve access and visibility during procedures, enabling dental professionals to deliver more precise treatments while ensuring maximum patient safety.